Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Illumina (ILMN) Q2 Earnings Top Estimates, 2021 View Up
11:30am, Friday, 06'th Aug 2021
Year-over-year improvement in segmental revenues in Q2 across all geographies exceeds Illumina's (ILMN) expectations.
Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved
09:06am, Friday, 06'th Aug 2021
Illumina will likely be allowed to buy Grail. But even without that deal, ILMN stock is very attractive, given the company's strong growth drivers.
Illumina Q2 Earnings Boosted By Robust Growth In Core Sequencing Business; Uplifts FY21 Outlook
07:55am, Friday, 06'th Aug 2021
Illumina Inc (NASDAQ: ILMN) reported after the close of the market on Thursday that its second-quarter revenues grew 78% Y/Y to $1.13 billion, beating the consensus of $1.01 billion, driven by stren
Illumina's (ILMN) CEO Francis deSouza on Q2 2021 Results - Earnings Call Transcript
10:24pm, Thursday, 05'th Aug 2021
Illumina's (ILMN) CEO Francis deSouza on Q2 2021 Results - Earnings Call Transcript
Illumina (ILMN) Beats Q2 Earnings and Revenue Estimates
07:01pm, Thursday, 05'th Aug 2021
Illumina (ILMN) delivered earnings and revenue surprises of 37.50% and 11.26%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Illumina: Q2 Earnings Insights
06:09pm, Thursday, 05'th Aug 2021
Shares of Illumina (NASDAQ:ILMN) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 201.61% over the past year to $1.87, which beat
Drug/Biotech Stocks Q2 Earnings Due on Aug 5: REGN, MRNA, ZTS, ILMN
12:13pm, Wednesday, 04'th Aug 2021
Let us take a look at what is in store for some of the drug/biotech stocks, which are scheduled to report on Aug 5.
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India
09:30pm, Tuesday, 03'rd Aug 2021
SAN DIEGO, Aug. 3, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in the M
3 Things About Illumina That Smart Investors Know
06:35am, Friday, 30'th Jul 2021
The company is cemented as the industry leader, but a crack is showing.
After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?
06:55am, Thursday, 29'th Jul 2021
Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position.
Illumina to Webcast Upcoming Investor Conference
06:30pm, Wednesday, 28'th Jul 2021
SAN DIEGO--(BUSINESS WIRE)---- $ILMN #ILMN--Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: UBS Genomics 2.0 and MedTech Innova
Illumina: Not All Rests With The Grail Acquisition
12:03pm, Tuesday, 27'th Jul 2021
The commentary surrounding Illumina seems to believe its fate stems on the Grail transaction. Nothing changes materially for the company if it fails, given strengths in the core business and key wins
Illumina-Grail $8B Merger Hit By European Commission's In-Depth Investigation
12:28pm, Friday, 23'rd Jul 2021
The European Commission has opened an in-depth, three-month investigation into Illumina Inc's (NASDAQ: ILMN) planned takeover of Grail, a deal valued between $7 billion to $8 billion. Last week, t
Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase
12:49pm, Thursday, 22'nd Jul 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase.
EU antitrust regulators to investigate Illumina, Grail deal
12:19pm, Thursday, 22'nd Jul 2021
EU antitrust regulators opened on Thursday a full-scale investigation into U.S. life sciences company Illumina Inc's proposed buy of cancer test maker Grail Inc, worried that the deal may curb innovat
